172 related articles for article (PubMed ID: 36809664)
1. Retrospective analysis of immunosuppressive and anti-thrombotic protocols in nonassociative immune mediated hemolytic anemia in dogs.
Weng J; Levy NA; Abbott HY; Mix JA; Wills RW; Mackin AJ; Thomason JM; Cridge H
J Vet Intern Med; 2023 Mar; 37(2):528-536. PubMed ID: 36809664
[TBL] [Abstract][Full Text] [Related]
2. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
Wang A; Smith JR; Creevy KE
J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of systemic hypertension in dogs with nonassociative (primary) immune-mediated hemolytic anemia (December 2016 to April 2019): 26 cases.
Hall GBF; Stoye DQ; Thomas EK; Culshaw GJ
J Vet Emerg Crit Care (San Antonio); 2022 Mar; 32(2):229-235. PubMed ID: 35080103
[TBL] [Abstract][Full Text] [Related]
5. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
West LD; Hart JR
J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
[TBL] [Abstract][Full Text] [Related]
6. Predicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case Registry.
Goggs R; Dennis SG; Di Bella A; Humm KR; McLauchlan G; Mooney C; Ridyard A; Tappin S; Walker D; Warman S; Whitley NT; Brodbelt DC; Chan DL
J Vet Intern Med; 2015; 29(6):1603-10. PubMed ID: 26473338
[TBL] [Abstract][Full Text] [Related]
7. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.
Piek CJ; van Spil WE; Junius G; Dekker A
BMC Vet Res; 2011 Apr; 7():15. PubMed ID: 21489250
[TBL] [Abstract][Full Text] [Related]
8. ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs.
Swann JW; Garden OA; Fellman CL; Glanemann B; Goggs R; LeVine DN; Mackin AJ; Whitley NT
J Vet Intern Med; 2019 May; 33(3):1141-1172. PubMed ID: 30847984
[TBL] [Abstract][Full Text] [Related]
9. Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs.
Helmond SE; Polzin DJ; Armstrong PJ; Finke M; Smith SA
J Vet Intern Med; 2010; 24(3):597-605. PubMed ID: 20384956
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
[TBL] [Abstract][Full Text] [Related]
11. The use of high-dose immunoglobulin M-enriched human immunoglobulin in dogs with immune-mediated hemolytic anemia.
Bestwick JP; Sharman M; Whitley NT; Kisielewicz C; Skelly BJ; Tappin S; Kellett-Gregory L; Seth M
J Vet Intern Med; 2022 Jan; 36(1):78-85. PubMed ID: 34779044
[TBL] [Abstract][Full Text] [Related]
12. Comparison of timing of relapse in dogs with nonassociative immune-mediated hemolytic anemia, thrombocytopenia, or polyarthritis.
Sparrow R; Swann JW; Glanemann B
J Vet Intern Med; 2024; 38(2):1035-1042. PubMed ID: 38308396
[TBL] [Abstract][Full Text] [Related]
13. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide.
Burgess K; Moore A; Rand W; Cotter SM
J Vet Intern Med; 2000; 14(4):456-62. PubMed ID: 10935898
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
Reimer ME; Troy GC; Warnick LD
J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
[TBL] [Abstract][Full Text] [Related]
15. Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs.
Cummings FO; Rizzo SA
J Small Anim Pract; 2017 Feb; 58(2):96-102. PubMed ID: 28160307
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia.
Goggs R
Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1327-1349. PubMed ID: 32814628
[TBL] [Abstract][Full Text] [Related]
17. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases.
Panek CM; Nakamura RK; Bianco D
J Vet Emerg Crit Care (San Antonio); 2015; 25(2):273-7. PubMed ID: 25773906
[TBL] [Abstract][Full Text] [Related]
18. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
[TBL] [Abstract][Full Text] [Related]
19. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999).
Grundy SA; Barton C
J Am Vet Med Assoc; 2001 Feb; 218(4):543-6. PubMed ID: 11229506
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006).
Horgan JE; Roberts BK; Schermerhorn T
J Vet Emerg Crit Care (San Antonio); 2009 Jun; 19(3):254-61. PubMed ID: 19691510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
